Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients - Marketwatch

NEW YORK, May 18, 2012 (BUSINESS WIRE) -- Pfizer Inc. (NYSE:PFE) announced today the results of studies on Lyrica(R) (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory ...

Pfizer Reports Results Of Studies On Lyrica Capsules CV - Quick Facts - NASDAQ

(RTTNews.com) - Pfizer Inc. (PFE) announced results of studies on Lyrica (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research designed to provide new insight into ...

Pfizer announces results from Lyrica clinical studies on fibromyalgia - News-Medical.Net

Pfizer Inc. (NYSE: PFE) announced today the results of studies on Lyrica ® (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research designed to provide new insight ...

Pfizer Exploratory Study Measures Effects Of Lyrica On Brain Activity In Fibromyalgia Patients - The FINANCIAL

The FINANCIAL -- Pfizer announced the results of studies on Lyrica capsules CV presented at the American Pain Society Annual Meeting in Honolulu. The studies included exploratory research designed to provide new insight into how Lyrica works in the brains ...

New Lyrica Oral Formulation For Patients With Dysphagia Available In UK - Medical News Today

Lyrica® (pregabalin) is now available in a new strawberry-flavored oral solution form in the UK, in order to benefit patients who have difficulty in taking medication in capsule form or for those with dysphagia (swallowing difficulty).

Pfizer Could Plummet Without Lipitor Replacement - Seekingalpha.com

Pfizer (PFE) is facing several problems at the moment. First, its patent on Lipitor is expiring. Second, it terminated the latest trial for Lyrica. Lyrica, which is intended to treat painful diabetic peripheral neuropathy, failed in its Phase III study.

Microsoft and 3 Dow 30 Giants Making Moves - Wall St. Cheat Sheet

Don’t Miss: Apple: We’re Cleaning Up the Cloud. Pfizer Inc. (NYSE:PFE) reported the results of studies on Lyrica capsules CV presented at the American Pain Society Annual Meeting in Honolulu. Exploratory research was included in the trials to provide ...

Pregabalin Fails to Improve Diabetic, HIV Neuropathy - Medscape News

May 8, 2012 — A phase 3 clinical trial of pregabalin (Lyrica, Pfizer) failed to meet its primary endpoint of improvement in mean pain scores relative to baseline in patients with inadequately treated painful diabetic neuropathy, the company announced.

Pfizer discontinues Phase III neuropathic pain trial - comcast.net

May 14, 2012 (Datamonitor via COMTEX News Network) -- Pfizer Inc. has discontinued a Phase III clinical trial of Lyrica, or pregabalin, in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain ...

Pfizer Q1 profit falls 19 pct on generic Lipitor - Yahoo Finance

"I am pleased with out first-quarter 2012 financial performance, which was driven by growth in certain brands including Celebrex, Enbrel and Lyrica, growth in key geographies such as China" and cost-cutting, CEO Ian Read said in a statement.